HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chun-Nan Yeh Selected Research

fenbufen

12/2017Dataset on the synthesis and characterization of boron fenbufen and its F-18 labeled homolog.
9/2017Synthesis and characterization of boron fenbufen and its F-18 labeled homolog for boron neutron capture therapy of COX-2 overexpressed cholangiocarcinoma.
3/2016Synthesis and Biological Evaluation of an (18)Fluorine-Labeled COX Inhibitor--[(18)F]Fluorooctyl Fenbufen Amide--For Imaging of Brain Tumors.
4/2013[123I]Iodooctyl fenbufen amide as a SPECT tracer for imaging tumors that over-express COX enzymes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chun-Nan Yeh Research Topics

Disease

100Neoplasms (Cancer)
01/2022 - 09/2002
32Cholangiocarcinoma
04/2022 - 04/2004
30Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
09/2021 - 04/2006
20Neoplasm Metastasis (Metastasis)
04/2022 - 12/2005
9Breast Neoplasms (Breast Cancer)
01/2021 - 06/2002
8Hypercalcemia (Milk Alkali Syndrome)
01/2016 - 12/2011
8Hepatocellular Carcinoma (Hepatoma)
11/2015 - 07/2002
7Stomach Neoplasms (Stomach Cancer)
01/2022 - 10/2009
7Carcinogenesis
01/2021 - 04/2004
7Wounds and Injuries (Trauma)
01/2020 - 01/2014
6Biliary Tract Neoplasms (Biliary Tract Cancer)
06/2021 - 01/2019
5Acute Cholecystitis
09/2021 - 01/2020
5Adenocarcinoma
07/2021 - 02/2010
5Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2021 - 07/2016
5Margins of Excision
11/2018 - 09/2002
5Carcinoma (Carcinomatosis)
07/2014 - 03/2004
5Pain (Aches)
05/2014 - 05/2004
4Necrosis
02/2022 - 11/2006
4Postoperative Pain
01/2021 - 05/2009
4Lymphatic Metastasis
01/2015 - 01/2009
3Thyroid Neoplasms (Thyroid Cancer)
01/2023 - 06/2017
3Hemorrhage
02/2022 - 09/2007
3Renal Cell Carcinoma (Grawitz Tumor)
01/2021 - 11/2014
3Hepatitis B
01/2021 - 07/2005
3Infections
01/2020 - 04/2005
3Brain Neoplasms (Brain Tumor)
03/2016 - 01/2014
3Liver Cirrhosis (Hepatic Cirrhosis)
09/2015 - 12/2002
3Chronic Kidney Failure (Chronic Renal Failure)
04/2015 - 04/2005
3Pancreatic Neoplasms (Pancreatic Cancer)
11/2014 - 01/2011
3Disease Progression
09/2014 - 06/2011
2Nasopharyngeal Carcinoma
06/2021 - 09/2018
2Anaplastic Thyroid Carcinoma
02/2021 - 12/2015
2Ataxia Telangiectasia (Louis Bar Syndrome)
11/2020 - 10/2020
2Fistula
10/2020 - 02/2006
2Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 12/2016
2Microsatellite Instability
01/2020 - 01/2020

Drug/Important Bio-Agent (IBA)

23Imatinib Mesylate (Gleevec)FDA Link
09/2021 - 04/2006
15hydroxide ionIBA
07/2018 - 12/2011
15Vitamin DFDA LinkGeneric
01/2017 - 01/2011
1419- nor- 2- (3- hydroxypropyl)- 1,25- dihydroxyvitamin D3IBA
07/2018 - 12/2011
13Proteins (Proteins, Gene)FDA Link
07/2021 - 07/2007
10Pharmaceutical PreparationsIBA
06/2021 - 01/2013
9Thioacetamide (Thioacetamid)IBA
01/2022 - 04/2004
9Sunitinib (Sutent)FDA Link
05/2021 - 04/2011
8GemcitabineFDA Link
11/2021 - 08/2016
7regorafenibIBA
04/2022 - 03/2016
6AntigensIBA
01/2022 - 12/2007
6Biomarkers (Surrogate Marker)IBA
04/2021 - 11/2014
6DNA (Deoxyribonucleic Acid)IBA
11/2020 - 03/2006
5CarbohydratesIBA
01/2022 - 05/2012
5Alkaline PhosphataseIBA
06/2021 - 12/2002
4Biological ProductsIBA
01/2022 - 02/2003
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019 - 03/2016
4fenbufenIBA
12/2017 - 04/2013
4EnzymesIBA
09/2017 - 04/2013
4AmidesIBA
03/2016 - 04/2013
4AlbuminsIBA
05/2013 - 04/2003
4Capsules (Microcapsules)IBA
04/2004 - 09/2002
3Hemoglobins (Hemoglobin)IBA
02/2022 - 04/2005
3Phosphoric Monoester Hydrolases (Phosphatases)IBA
07/2021 - 01/2015
3Protein Isoforms (Isoforms)IBA
07/2021 - 04/2006
3Cisplatin (Platino)FDA LinkGeneric
07/2021 - 07/2014
3Hormones (Hormone)IBA
01/2021 - 01/2012
3Messenger RNA (mRNA)IBA
11/2020 - 02/2009
3Immune Checkpoint InhibitorsIBA
11/2020 - 01/2020
3Aurora Kinase AIBA
09/2018 - 10/2012
3Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
07/2017 - 04/2006
3Heat-Shock Proteins (Heat-Shock Protein)IBA
06/2017 - 01/2013
3Calcitriol Receptors (Calcitriol Receptor)IBA
01/2017 - 06/2014
3NitrogenIBA
08/2009 - 04/2003
3Urea (Carbamide)FDA LinkGeneric
08/2009 - 04/2003
2MicroRNAs (MicroRNA)IBA
09/2021 - 01/2020
2palbociclibIBA
06/2021 - 09/2018
2RNA (Ribonucleic Acid)IBA
06/2021 - 09/2018
2Polo-like KinasesIBA
02/2021 - 01/2019
2BI 6727IBA
02/2021 - 01/2019
2EverolimusFDA Link
01/2021 - 01/2019
2DNA VaccinesIBA
11/2020 - 12/2007
2MucinsIBA
01/2020 - 03/2009
2Therapeutic UsesIBA
01/2019 - 06/2017
2Estrogen ReceptorsIBA
07/2018 - 01/2012
2Celecoxib (Celebrex)FDA Link
01/2018 - 01/2013
2BoronIBA
12/2017 - 09/2017

Therapy/Procedure

24Therapeutics
01/2022 - 07/2005
15Hepatectomy
03/2022 - 12/2002
11Drug Therapy (Chemotherapy)
06/2021 - 06/2004
8Radiotherapy
01/2019 - 03/2005
7Gastrectomy
08/2020 - 10/2009
6Laparotomy
08/2020 - 07/2002
5Pancreaticoduodenectomy
01/2022 - 11/2005
5Cholecystectomy
10/2020 - 02/2006
4Cholecystostomy
09/2021 - 08/2020
4Laparoscopic Cholecystectomy
01/2018 - 03/2004
3Adjuvant Chemotherapy
01/2020 - 02/2010
3Contraindications
08/2009 - 04/2005
3Length of Stay
01/2007 - 01/2002
2Precision Medicine
01/2022 - 01/2021
2Cytoreduction Surgical Procedures
01/2021 - 03/2017
2Immunotherapy
01/2020 - 12/2007
2Splenectomy
01/2020 - 04/2010